The Journal of Organic Chemistry
Article
reduced pressure, and the residue was dissolved in DCM and washed
twice with saturated 5% aq NaHSO3. The organic phase was dried
over Na2SO4 and evaporated to dryness. The product was purified by
silica gel chromatography, eluting with a mixture of EtOAc containing
5% MeOH. Compound 2b was obtained as solid foam in 73% yield
5476, 54.72, and 54.71 (CH3OP); 46.37 (spiro C of Piv); 38.40, 36.31,
36.28, and 36.26 (CH2S); 27.22; 25.25 and 25.23 (CH3 of Piv); 27.10
(CH3 of isopropylidene); 17.55, 17.53, and 17.51 (CHCH3); 13.95
(CH3CH2O). 31P NMR (202 MHz, CD3CN): δ = −0.41, −0.44,
−0.57, and −0.60 ppm. ESI+-HRMS: m/z [M + Na]+ calcd for
C26H39N2NaO13PS 673.1803, found 673.1832.
1
(0.52 g). H NMR (500 MHz, CDCl3): δ = 9.15 (br, 1H, NH); 7.96
(dd, 2H, J = 10.00 Hz, J = 2.00 Hz, Bz); 7.58 (t, 1H, J = 10.00 Hz, Bz);
7.45 (t, 2H, J = 10.00 Hz, Bz); 7.35 (d, 1H, J = 10.00 Hz, H6); 5.73
(m, 2H, H5 and H1′); 4.93 (m, 1H, H2′); 4.86 (m, 1H, H3′); 4.32
(m, 1H, H4′), 4.29−4.24 (m, 2H, H5″ and H5′); 4.16−4.12 (m, 4H,
CH2O and CH2S); 3.79 and 3.76 (s, 3H, POCH3); 1.55 (s, 3H, CH3);
1.34 (s, 3H, CH3); 1.33 (s, 6H, 2 × CH3). 13C NMR (126 MHz,
CDCl3): δ = 205.40 (CO); 190.61 (SCO); 163.23 (4′CO);
149.98 (C2′CO); 141.97 and 141.91 (H6); 136.23 (Bz); 133.81
(Bz); 128.74 (Bz); 127.42 (Bz); 114.70 (spiro C of isopropylidene);
102.76 and 102.73 (C5); 93.98 and 93.94 (C1′); 85.34 and 85.28
(C4′); 84.33 (C2′); 80.61 and 80.55 (C3′); 73.07 and 73.02
(CH2OH); 67.13 and 67.08 (C5′); 54.77 and 54.73 (CH3OP);
48.84 and 48.82 (spiro C); 36.42 (CH2S); 27.11; 25.27 and 25.25
(CH3) ; 21.71 and 21.67 (CH3); 21.65 (CH3). 31P NMR (202 MHz,
CDCl3): δ = −0.28 and −0.40 ppm. ESI+-HRMS: m/z [M + H]+ obsd
613.1617, calcd for C26H34N2O11PS 613.1615. ESI+-HRMS: m/z [M +
Na]+ calcd for C26H33N2NaO11PS 635.1435, found 635.1424.
4-Acetylthio-2,2-dimethyl-3-oxobutyl Bis(2′,3′-isopropylidene-2′-
C-methyluridin-5′-yl) Phosphate (9). 2′,3′-O-Isopropylidene-2′-C-
methyluridine26,29 (0.60 mmol; 0.18 g) was dried over P2O5 for 2
days and dissolved in dry DCM (4 mL) under nitrogen. Dry Et3N (5.0
mmol; 0.70 mL) and 1,1-dichloro-N,N-diisopropylphosphinamine
(0.50 mmol; 93 μL) were added. After the reaction mixture was
stirred at rt for 1 h, the mixture was passed through a short silica gel
column eluting with EtOAc that contained 0.5% Et3N. The solvents
were removed under reduced pressure. The residue was coevaporated
three times from dry MeCN and dissolved in dry MeCN (1.5 mL), (4-
hydroxy-3,3-dimethyl-2-oxobutyl)ethanethioate (7a) (1.50 mmol, 0.29
g) in dry MeCN (1.5 mL) and 1-H-tetrazole (1.50 mmol, 3.33 mL of
0.45 mol L−1 solution in MeCN) were added under nitrogen, and the
reaction mixture was stirred at rt for 2.5 h. The phosphite ester formed
was oxidized with I2 in a 4:2:1 mixture of THF, H2O, and 1,2-lutidine
by stirring overnight at room temperature. The product was isolated
by conventional 5% aq NaHSO3/DCM workup. The crude product
was purified on a silica gel column eluting with 2 to 6% MeOH in
DCM. Compound 9 was obtained as a white solid in 10% yield (52
2′,3′-O-Isopropylideneuridine 5′-(Methyl 4-acetylthio-2,2-di-
methyl-3-oxobutyl) Phosphate (2a). Phosphotriester 2a was
prepared in a similar manner as 2b, but by using S-(4-hydroxy-3,3-
dimethyl-2-oxobutyl) ethanethioate (7a) instead of S-(4-hydroxy-3,3-
dimethyl-2-oxobutyl) benzothioate (7b). The crude product 2a was
purified on a silica gel column eluting with a mixture of ethyl acetate
and methanol (95:5, v/v). The product 2a was obtained as solid foam
1
mg). H NMR (500 MHz, CDCl3): δ = 9.56 (s, 2H, NH); 7.53 (d,
1H, J = 5.00 Hz, H6); 7.51 (d, 1H, J = 5.00 Hz, H6); 6.02 (s, 1H,
H1′); 6.01 (s, 1H, H1′); 5.74 (d, 2H, J = 5.00 Hz, H5); 4.43−4.41 (m,
2H, H3′), 4.38−4.32 and 4.18−4.12 (m, 8H, H4′, H5′, H5″ and
CH2O); 3.94 (s, 2H, CH2S); 2.35 (s, 3H, CH3CO); 1.31 (s, 3H,
CH3); 1.30 (s, 3H, CH3); 1.28 (s, 3H, CH3); 1.26 (s, 3H, CH3). 13C
NMR (126 MHz, CDCl3): δ = 205.13 (CO); 194.46 (SCO);
163.28 (C4); 150.11 (C2); 140.67 (C6); 114.92 (spiro C of
isopropylidene); 102.22 (C5); 93.29 (C1′); 89.80 and 89.77 (C2′);
85.37 and 85.34 (C3′); and 81.68 (C4′); 73.30 and 73.26 (CH2O);
67.38 and 67.33 (C5′); 48.66 and 48.60 (spiro C); 36.26 (CH2S);
30.23 (CH3 of Ac); 28.46, 28.44, 27,57 and 27.55 (CH3 of
isopropylidene); 21.64 and 21.55 (CH3); 19.38 and 19.36 (2′-CH3).
31P NMR (202 MHz, CDCl3): δ = −1.21 ppm. ESI+-HRMS: m/z [M
1
in 29% yield (325 mg). H NMR (500 MHz, CDCl3): δ = 10.04 (br,
1H, NH); 7.33 (d, 1H, J = 8.00 Hz, H6); 5.68 (m, 2H, H5 and H1′);
4.90 (m, 1H, H2′); 4.79 (m, 1H, H3′); 4.25 (m, 1H, H4′), 4.21−4.15
(m, 2H, H5″ and H5′); 4.04 (m, 2H, CH2O); 3.89 (d, 2H, J = 3.00
Hz, CH2S); 3.70 and 3.68 (d, 3H, J = 1.00 Hz, POCH3); 2.29 (2s,
CH3CO); 1.49 (s, 3H, CH3); 1.28 (s, 3H, CH3); 1.21 (s, 3H, CH3)
1.20 (s, 3H, CH3). 13C NMR (126 MHz, CDCl3): δ = 205.34 (C
O); 194.44 and 194.43 (SCO); 163.68 (C4); 150.22 (C2); 142.17
(C6); 114.55 (spiro C of isopropylidene); 102.66 and 102.64 (C5);
93.97 and 93.90 (C1′); 85.36, 85.34, 85.31, and 85.28 (C4′); 84.28
(C2′); 80.63 and 80.58 (C3′); 72.91 and 72.89 (CH2OH); 67.18 and
67.14 (C5′); 54.73, 54.68, and 54.64 (CH3OP); 48.67, 48,65, 48,60
and 48.58 (spiro); 36. 33 (CH2S); 30.15 (CH3); 27.06 (CH3); 25.23
and 25.21 (CH3); 21.52, 21.50, 21.49 (CH3). 31P NMR (202 MHz,
CDCl3): δ = −0.40 and −0.50 ppm. ESI+-MS: m/z [M + H]+ obsd
551.1454, calcd for C21H32N2O11PS 551.1459. ESI+-MS: m/z [M +
Na]+ calcd for C21H31N2NaO11PS 573.1278 found 573.1282.
+ H]+ calcd for C34H48N4O16PS 831.2518, found 831.2487.
4-Acetylthio-2,2-dimethyl-3-oxobutyl Bis(2′-C-methyluridin-5′-yl)
Phosphate (3). Compound 9 was dissolved in 80% aqueous AcOH (5
mL) and stirred at 90 °C for 36 h. The solvent was removed under
reduced pressure and the residue was coevaporated two times from
water. The crude product was purified on a silica gel column with
gradient elution from 5% to 10% MeOH in DCM. Compound 3 was
obtained as solid in 42% yield (20 mg). 1H NMR (500 MHz,
CD3OD): δ = 7.65 (d, 1H, J = 5.00 Hz, H6); 7.63 (d, 1H, J = 5.00 Hz,
H6); 5.97 (s, 2H, H1′); 4.53−4.47 (m, 2H, H3′); 4.43−4.37 (m, 2H,
CH2O); 4.30−4.20 (m, 2H, H4′); 4.13−4.11 (m, 2H, H5″), 4.07 (s,
2H, CH2S); 3.81 (t, 2H, J = 10.00 Hz, H5′); 2.34 (s, 3H, CH3 of Ac);
1.30 (s, 6H, 2 × 2′-CH3); 1.18 (s, 6H, 2 × CH3). 13C NMR (126
MHz, CDCl3): δ = 205.84 (CO); 194.86 (SCO); 164.44 (4′C
O); 150.87 (C2′CO); 140.62 (C6); 101.69 (C5); 92.5 (C1′); 80.04
and 80.05, 78.19 (C4′, C3′ and C2′); 73.17, 72.89, and 72.84
(CH2O); 66.66 (C5′); 48.13 (spiro C); 35.89 (CH2S); 28.65 (CH3 of
Ac); 20.42 (CH3); 18.83 (2′-CH3). 31P NMR (202 MHz, CDCl3): δ =
−1.88. ESI+-HRMS: m/z [M + H]+ calcd for C28H40N4O16PS
751.1892, found 751.1880.
Kinetic Measurements. The reactions were carried out in sealed
tubes immersed in a thermostated water bath (37.0 0.1 °C). The
hydronium ion concentration of the reaction solutions (3.0 mL) was
adjusted with sodium hydroxide and N-[2-hydroxyethyl]piperazine-N-
[2-ethanesulfonic acid] (HEPES) buffer. The ionic strength of the
solutions was adjusted to 0.1 mol L−1 with sodium chloride. The
hydronium ion concentration of the buffer solutions was calculated
with the aid of the known pKa values of the buffer acid under the
experimental conditions. The initial substrate concentration was ca. 0.2
mmol L−1.
2′,3′-O-Isopropylideneuridine 5′-(Methyl 2-ethoxycarbonyl-2-
methyl-3-oxo-4-pivaloylthiobutyl) Phosphate (2c). Phosphotriester
2c was prepared in a similar manner as 1a, but by using ethyl 2-
(hydroxymethyl)-2-methyl-3-oxo-4-(pivaloylthio)butanoate (5c) in-
stead of ethyl-4-(acetylthio)-2-(hydroxymethyl)-2-methyl-3-oxobuta-
noate (5a). The crude product was purified on a silica gel column
eluting with a mixture of EtOAc and MeOH (95:5, v/v). The product
1
2c was obtained as solid foam in 13% yield (0.10 g). H NMR (500
MHz, CDCl3): δ = 9.75 (s br. 1H, NH); 7.34 (d, 1H, J = 8.00 Hz,
H6); 5.73−5.71 (m, 2H, H1′ and H5); 4.93−4.91 (m, 1H, H2′),
4.84−4.82 (m, 1H, H3′); 4.43−4.35 (m, 1H,); 4.32−4.27 (dd, 1H,
H4′); 4.26−4.19 (m, 4H, H5″, H5′ and OCH2CH3); 3.93−3.83 (m,
3H, H4′ and CH2S); 3.74−3.72 (4s, 3H, POCH3); 1.53 (s, 3H,
CCH3); 1.53 (s, 3H, CH3 of isopropylidene); 1.32 (s, 3H, CH3 of
Piv); 1.26 (t, 3H, J = 7.00 Hz, CH3CH2O); 1.21 (s, 3H, CH3 of Piv);
1.85 (s, 3H, CH3 of isopropylidene). 13C NMR (126 MHz, CDCl3): δ
= 204.79 and 204.77 (CO); 198.91,198.86, 198.85, and 198.83
(SCO); 169.52 and 169.49 (OCO), 163.59 (C4); 150.16 and
150.14 (C2); 142.08 and 142.04 (H6); 114.68 and 114.65 (C of
isopropylidene); 102.74 and 102.72 (C5); 93.92 and 93.89 (C1′);
85.30, 85.24, and 85.18 (C4′); 84.29 and 84.27 (C2′); 80.55 (C3′);
69.46 and 69.43 (POCH2); 67.22 and 67.19 (C5′); 62.34
(OCH2CH3); 60.15−60.03 (spiro C of protecting group); 54.80,
958
dx.doi.org/10.1021/jo302421u | J. Org. Chem. 2013, 78, 950−959